CD86 and cancer: CD86 was observed to be prognostic in four cancer types (Figure 3A), i.e., LGG (HR = 1.5, 95%CI [1.2, 1.8], log-rank P < 0.001) (Figure 3B), SKCM (HR = 0.71, 95%CI [0.62, 0.81], log-rank P < 0.001) (Figure 3C), UVM (HR = 2.3, 95%CI [1.3, 4.1], log-rank P < 0.001) (Figure 3D) and Testicular Germ Cell Tumor (TGCT; HR = 3.9, 95%CI [1, 15], log-rank P = 0.022) (Figure 3E).